Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
about
Schistosomiasis vaccinesPreclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemicSchistosomiasis vaccines: where do we stand?Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?Complement plays a minimal role in Sm-p80-mediated protection against Schistosoma mansoni.Combined TLR7/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine.Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate modelsSchistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum).Schistosome Vaccine Adjuvants in Preclinical and Clinical Research.Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni.Development of a schistosomiasis vaccine.CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.Immuno-evasive tactics by schistosomes identify an effective allergy preventative.Immunomodulatory effect of R848 on cytokine production associated with Schistosoma mansoni infection.The self-curing phenomenon of schistosome infection in rhesus macaques: insight from in vitro studies.
P2860
Q24598949-C7FEAD66-0D05-4CD5-8C64-1DAAA6A15021Q24635389-9584A2FC-E690-428E-B7B5-773B47E71FD1Q28066042-CB3B429C-3609-4555-BABA-7F02C2EF69D6Q28081158-C34D1117-C899-4D83-B938-DA5FBFB29851Q34033792-85C76F1C-261E-432B-B493-C6B9B6001F1EQ34675128-6D1B1BCD-3F20-43B6-A524-A11549E3545FQ34713889-E57585F0-1972-446E-B3DE-4EF452166570Q34899535-8ABAFF56-5C65-412A-A9FB-39DB539C82AEQ35826651-E5029AF8-D4AB-4D12-9478-978310A06A7CQ36368518-3C1B0FE5-66A3-4740-A185-0E9675F33835Q37350747-1BA8AE42-6CBE-4C9B-BC7E-4BF6566739DAQ37565174-BE63E8EA-2229-421A-97A3-251098C10473Q37603033-D4FE83AD-5F5B-4A55-B89D-8560AB3C05F7Q38124064-B5C3DD65-C58E-45C9-BCD3-5D5B932CA664Q41373939-7F35B6B0-AF84-4677-B6CD-2210AF64A08DQ43568745-48610E3C-343B-479E-81AB-7394D55F9BA3Q47294803-EF956B46-66B0-4C6D-88CD-015F2E9D2B79
P2860
Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Protective effects of Sm-p80 i ...... h Schistosoma mansoni in mice.
@ast
Protective effects of Sm-p80 i ...... h Schistosoma mansoni in mice.
@en
Protective effects of Sm-p80 i ...... h Schistosoma mansoni in mice.
@nl
type
label
Protective effects of Sm-p80 i ...... h Schistosoma mansoni in mice.
@ast
Protective effects of Sm-p80 i ...... h Schistosoma mansoni in mice.
@en
Protective effects of Sm-p80 i ...... h Schistosoma mansoni in mice.
@nl
prefLabel
Protective effects of Sm-p80 i ...... h Schistosoma mansoni in mice.
@ast
Protective effects of Sm-p80 i ...... h Schistosoma mansoni in mice.
@en
Protective effects of Sm-p80 i ...... h Schistosoma mansoni in mice.
@nl
P2093
P2860
P1476
Protective effects of Sm-p80 i ...... h Schistosoma mansoni in mice.
@en
P2093
Afzal A Siddiqui
Weidong Zhang
Workineh Torben
Zahid Noor
P2860
P304
P356
10.1016/J.IJID.2010.02.2266
P577
2010-07-13T00:00:00Z